1. Checkpoint inhibition in the treatment of multiple myeloma: A way to boost innate-like T cell anti-tumor function?. (September 2018) Authors: Venken, Koen; Favreau, Mérédis; Gaublomme, Djoere; Menu, Eline; Vanderkerken, Karin; Elewaut, Dirk Journal: Molecular immunology Issue: Volume 101(2018:Sep.) Page Start: 521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Conversion of ATP to adenosine by CD39 and CD73 in multiple myeloma can be successfully targeted together with adenosine receptor A2A blockade. Issue 1 (14th May 2020) Authors: Yang, Rui; Elsaadi, Samah; Misund, Kristine; Abdollahi, Pegah; Vandsemb, Esten Nymoen; Moen, Siv Helen; Kusnierczyk, Anna; Slupphaug, Geir; Standal, Therese; Waage, Anders; Slørdahl, Tobias S; Rø, Torstein Baade; Rustad, Even; Sundan, Anders; Hay, Carl; Cooper, Zachary; Schuller, Alwin G; Woessne... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Epigenetic treatment of multiple myeloma mediates tumor intrinsic and extrinsic immunomodulatory effects. (3rd October 2018) Authors: De Beck, Lien; Melhaoui, Sarah; De Veirman, Kim; Menu, Eline; De Bruyne, Elke; Vanderkerken, Karin; Breckpot, Karine; Maes, Ken Journal: Oncoimmunology Issue: Volume 7:Number 10(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Identification of the immune checkpoint signature of multiple myeloma using mass cytometry‐based single‐cell analysis. Issue 5 (29th April 2020) Authors: Wang, Jinheng; Zheng, Yongjiang; Tu, Chenggong; Zhang, Hui; Vanderkerken, Karin; Menu, Eline; Liu, Jinbao Journal: Clinical & translational immunology Issue: Volume 9:Issue 5(2020) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity. Issue 1 (10th July 2016) Authors: De Veirman, Kim; Wang, Jinheng; Xu, Song; Leleu, Xavier; Himpe, Eddy; Maes, Ken; De Bruyne, Elke; Van Valckenborgh, Els; Vanderkerken, Karin; Menu, Eline; Van Riet, Ivan Journal: Cancer letters Issue: Volume 377:Issue 1(2016) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Molecular mechanisms, current management and next generation therapy in myeloma bone disease. Issue 1 (2nd January 2018) Authors: Heusschen, Roy; Muller, Joséphine; Duray, Elodie; Withofs, Nadia; Bolomsky, Arnold; Baron, Frédéric; Beguin, Yves; Menu, Eline; Ludwig, Heinz; Caers, Jo Journal: Leukemia & lymphoma Issue: Volume 59:Issue 1(2018) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression. Issue 2 (7th April 2016) Authors: Wang, Jinheng; De Veirman, Kim; Faict, Sylvia; Frassanito, Maria Antonia; Ribatti, Domenico; Vacca, Angelo; Menu, Eline Journal: Journal of pathology Issue: Volume 239:Issue 2(2016) Page Start: 162 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway. (1st February 2019) Authors: De Veirman, Kim; Menu, Eline; Maes, Ken; De Beule, Nathan; De Smedt, Eva; Maes, Anke; Vlummens, Philip; Fostier, Karel; Kassambara, Alboukadel; Moreaux, Jérôme; Van Ginderachter, Jo A.; De Bruyne, Elke; Vanderkerken, Karin; Van Valckenborgh, Els Journal: Cancer letters Issue: Volume 442(2019) Page Start: 233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Stimulation of invariant natural killer T cells by α‐Galactosylceramide activates the JAK‐STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model. (21st August 2014) Authors: Nur, Haneen; Rao, Luigia; Frassanito, Maria Antonia; De Raeve, Hendrik; Ribatti, Domenico; Mfopou, Josué Kunjom; Van Valckenborgh, Els; De Bruyne, Elke; Vacca, Angelo; Vanderkerken, Karin; Menu, Eline Journal: British journal of haematology Issue: Volume 167:Number 5(2014:Dec.) Page Start: 651 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. System Xc− inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance. (1st June 2022) Authors: Wang, Fang; Oudaert, Inge; Tu, Chenggong; Maes, Anke; Van der Vreken, Arne; Vlummens, Philip; De Bruyne, Elke; De Veirman, Kim; Wang, Yanmeng; Fan, Rong; Massie, Ann; Vanderkerken, Karin; Shang, Peng; Menu, Eline Journal: Cancer letters Issue: Volume 535(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗